Syndrome of arterial hypertension
- Authors: Khalilova U.A.1, Skvortsov V.V.2, Zadumina D.N.2, Bangarov R.Y.3
-
Affiliations:
- Federal State Budgetary Educational Institution of Higher Education «Peoples' Friendship University of Russia» of the ministry of higher education and science health of the Russian Federation
- Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation
- Academician Shumakov National Medical Research Center for Transplantology and Artificial Organs of the ministry of health of the Russian Federation
- Issue: Vol 24, No 1 (2022)
- Pages: 36-39
- Section: Profession: theory and practice
- URL: https://journals.rcsi.science/0025-8342/article/view/146902
- DOI: https://doi.org/10.29296/25879979-2022-01-05
- ID: 146902
Cite item
Open Access
Access granted
Subscription Access
Abstract
Arterial Hypertension is the leading risk factor for the development of cardiovascular diseases. AH is commonly understood as a chronically occurring disease in which an increase in blood pressure is not associated with the identification of obvious causes leading to the development of secondary forms of hypertension. AH prevails among all forms of hypertension; its prevalence is over 90%. Сardiovascular diseases and cerebrovascular disease, presented in official statistics as diseases of the circulatory system, are the leading causes of mortality in the Russian Federation, their share of the total number of deaths from all causes accounts for 48% of deaths. In the Russian population, the prevalence of hypertension among men is slightly higher, in some regions it reaches 47%, among women the prevalence of hypertension is about 40% [1]. According to experts, by 2025 the number of people with hypertension will increase by 15-20%, reaching about 1.5 billion people. This article is devoted to the etiology, pathogenesis, classification, diagnosis, approaches to the treatment of hypertension.
Full Text
##article.viewOnOriginalSite##About the authors
Ulkar A. Khalilova
Federal State Budgetary Educational Institution of Higher Education «Peoples' Friendship University of Russia» of the ministry of higher education and science health of the Russian Federation
Email: khalilova.ulia@yandex.ru
postgraduate
Russian FederationVsevolod V. Skvortsov
Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation
Email: vskvortsov1@ya.ru
Doctor of Medicine, Associate Professor of the Department of Internal Medicine
Russian FederationDaria N. Zadumina
Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation
Email: darya29.08@mail.ru
student
Russian FederationRizvan Yu. Bangarov
Academician Shumakov National Medical Research Center for Transplantology and Artificial Organs of the ministry of health of the Russian Federation
Author for correspondence.
Email: rizvan.bangarov@yandex.ru
resident
Russian FederationReferences
- Arutyunov G.P., Rylova A.K. Beta-blockers in clinical practice // Heart failure. - 2001. - Vol. 2, No. 2. - pp.92-94.
- Order of the Ministry of Health of the Russian Federation No. 918n dated November 15, 2012 «On approval of the Procedure for providing medical care to patients with cardiovascular diseases».
- The standard of medical care for patients with essential primary hypertension (when providing specialized care), approved by Order No. 419 of the Ministry of Health and Social Development of the Russian Federation dated June 13, 2007.
- Order of the Ministry of health of the Russian Federation of July 15, 2016 No. 520н «On approval of criteria for assessing the quality of medical care.»
- The order of the Ministry of health of the Russian Federation dated 28.02.2019, No. 103н «On approval of the procedure and timing of the development of clinical recommendations for their revision, standard form of clinical guidelines and requirements of their structure, composition and scientific validity to be included in clinical guidelines information» (Was 08.05.2019 № 54588).
- Chazova I.E., Oshchepkova E.V. The results of the implementation of the Federal target program for the prevention and treatment of hypertension in Russia in 2002-2012. // Edition: Bulletin of the Russian Academy of Medical Sciences, 2013.
- Handbook of Cardiology, ed. Academician E.I.Chazova, in 4 volumes (volume 1) // Praktika, 2014.
- Rational pharmacotherapy of cardiovascular diseases. Ruk. for practice. doctors/2nd edition. Under the general editorship of E.I.Chazov, Yu.A. Karpov // M.: Litera, 2013.p.
- Ryabykina G.V., Sobolev A.V. ECG monitoring // M: Medpraktika, 2005.
- Functional diagnostics in cardiology. Ed. Vasyuk Yu.A. // M.:Practical Medicine 2009.
- Frishman W., Bryzinski B., Coulson L. et al. A multifactorial trial design to assess combination therapy in hypertension // Arch. Intern. Med. 1994; 154: 1461–1468.
- Ambrosioni E., Leonetti G., Pessina A. et al. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy // J. Hypertens. 2000; 18: 1691–1699.
- Lee J., Kusek J., Greene P. Et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study // Am. J. Hypertens. 1996; 9: 719-725.
- Khamidullayeva G., Khafizova L., Abdullayeva G. High-risk hypertension: efficacy of combination antihypertensive drug and non-drug antihypertensive therapy, 2019. (30). № 3. p. 68-72
- Barinov E., Faber T., Sokhina V. Arterial hypertension: possible pathogenetic mechanisms for the development of chronic brain ischemia Vrach 2020 (31). № 9. p. 5-10.
Supplementary files
